“They’re not even trying to be subtle”
Carbondale, Ill. – A special interest lobbying group, supported and funded by Big Pharma, has thrown its support to 12th District Republican Congressman Mike Bost.
In paid ads running in 12th District newspapers Sunday, the “Alliance for Patient Access” says it has given Bost its “2020 Champion of Patient Access” award.
The Associated Press reported last year that the “’Alliance for Patient Access’ gives off a consumer-friendly vibe but is bankrolled by the powerful pharmaceutical industry.”
“They’re not even trying to be subtle,” said Ray Lenzi of Makanda, the Democratic candidate seeking to take over Bost’s seat. “There can no longer be any doubt…Mr. Bost is clearly in the tank for Big Pharma. He’s actually bragging about it.”
Steven Knievel of the nonpartisan watchdog group Public Citizen told the AP that, “Groups like the Alliance for Patient Access often act as foils for the pharmaceutical industry instead of advancing patient interests. They advocate for policies where industry and patient interests align. But any time drug prices are on the table, they toe the line of their corporate backers.”
Lenzi noted, “It’s part of a pattern that has followed Mr. Bost throughout his entire political career…service to his constituents takes a back seat to big money.
“Mr. Bost has a terrible record when it comes to health care in this country and in the 12th District,” said Lenzi. “He may push Medicare access, but when Big Pharma comes to call, Bost will fall in line in the name of profits for his corporate masters.
“Don’t count on ‘No Show’ Mike when it comes time to pass legislation that would keep the high costs of prescription medicines in check” said Lenzi, “Its really a shame that Bost hides from ‘We the People’ who live in the 12th District and then brags about support from special interest groups that seek to hurt those who need help the most. He is clearly out of touch with the needs of his district. It’s just one more reason why it’s time to retire Mike Bost.”
Recent Comments